Lantern Other Current Assets vs Total Current Assets Analysis
LTRN Stock | USD 5.50 0.04 0.73% |
Lantern Pharma financial indicator trend analysis is infinitely more than just investigating Lantern Pharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lantern Pharma is a good investment. Please check the relationship between Lantern Pharma Other Current Assets and its Total Current Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantern Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.
Other Current Assets vs Total Current Assets
Other Current Assets vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lantern Pharma Other Current Assets account and Total Current Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Lantern Pharma's Other Current Assets and Total Current Assets is 0.91. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Lantern Pharma, assuming nothing else is changed. The correlation between historical values of Lantern Pharma's Other Current Assets and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Lantern Pharma are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Other Current Assets i.e., Lantern Pharma's Other Current Assets and Total Current Assets go up and down completely randomly.
Correlation Coefficient | 0.91 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Most indicators from Lantern Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lantern Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantern Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.As of the 29th of April 2024, Selling General Administrative is likely to drop to 5,684. In addition to that, Issuance Of Capital Stock is likely to drop to 0.00
Lantern Pharma fundamental ratios Correlations
Click cells to compare fundamentals
Lantern Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lantern Pharma fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.4M | 20.4M | 74.0M | 58.8M | 43.6M | 36.4M | |
Other Current Liab | 489.3K | 552.3K | 2.2M | 2.7M | 2.5B | 2.6B | |
Total Current Liabilities | 489.3K | 552.3K | 2.3M | 2.8M | 2.7M | 1.7M | |
Total Stockholder Equity | 943.3K | 19.7M | 71.6M | 56.0M | 40.9M | 34.6M | |
Net Tangible Assets | 943.0K | 19.7M | 71.6M | 56.0M | 64.4M | 32.6M | |
Property Plant And Equipment Net | 8.8K | 21.5K | 216.2K | 95.7K | 280.4K | 294.4K | |
Net Debt | (1.2M) | (19.1M) | (51.3M) | (37.1M) | (21.7M) | (22.8M) | |
Retained Earnings | (6.8M) | (12.7M) | (25.0M) | (39.3M) | (55.2M) | (52.5M) | |
Accounts Payable | 489.3K | 552.3K | 2.2M | 2.7M | 2.5M | 1.6M | |
Cash | 1.2M | 19.2M | 51.5M | 37.2M | 21.9M | 24.1M | |
Non Current Assets Total | 199.8K | 122.7K | 1.2M | 113.6K | 306.3K | 363.2K | |
Cash And Short Term Investments | 1.2M | 19.2M | 70.7M | 55.2M | 41.3M | 34.5M | |
Common Stock Shares Outstanding | 6.3M | 6.2M | 10.9M | 10.9M | 10.8M | 9.4M | |
Liabilities And Stockholders Equity | 1.4M | 20.4M | 74.0M | 58.8M | 43.6M | 36.4M | |
Other Stockholder Equity | 7.7M | 32.4M | 96.7M | 95.7M | 96.3M | 61.0M | |
Total Liab | 489.3K | 660.8K | 2.4M | 2.8M | 2.7M | 1.8M | |
Net Invested Capital | 929.3K | 19.8M | 71.6M | 56.0M | 40.9M | 34.7M | |
Total Current Assets | 1.2M | 20.2M | 72.7M | 58.7M | 43.3M | 36.1M | |
Capital Stock | 25.4K | 622.0 | 1.1K | 1.1K | 1.1K | 1.0K | |
Net Working Capital | 743.5K | 19.7M | 70.4M | 55.9M | 40.7M | 34.3M | |
Property Plant Equipment | 8.8K | 21.5K | 216.2K | 48.0K | 55.2K | 65.8K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lantern Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lantern Pharma's short interest history, or implied volatility extrapolated from Lantern Pharma options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantern Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Lantern Stock analysis
When running Lantern Pharma's price analysis, check to measure Lantern Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lantern Pharma is operating at the current time. Most of Lantern Pharma's value examination focuses on studying past and present price action to predict the probability of Lantern Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lantern Pharma's price. Additionally, you may evaluate how the addition of Lantern Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Stocks Directory Find actively traded stocks across global markets |
Is Lantern Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lantern Pharma. If investors know Lantern will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lantern Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Return On Assets (0.22) | Return On Equity (0.33) |
The market value of Lantern Pharma is measured differently than its book value, which is the value of Lantern that is recorded on the company's balance sheet. Investors also form their own opinion of Lantern Pharma's value that differs from its market value or its book value, called intrinsic value, which is Lantern Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lantern Pharma's market value can be influenced by many factors that don't directly affect Lantern Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lantern Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lantern Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lantern Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.